Mnemo Therapeutics
Nil Ege, PhD, has a strong background in cancer biology and cell signaling. With experience in various research institutions such as The Francis Crick Institute and UCL, Nil's expertise lies in target discovery and validation. Their work has focused on understanding the role of mechanotransduction in fibroblasts and T cell migration, contributing significantly to the field of cancer research.
Previous companies
This person is not in any offices
Mnemo Therapeutics
1 followers
Mnemo Therapeutics is a biotechnology company focused on developing powerful cell therapies that create accessible cures for solid tumors and blood cancers. Its EnfiniT platform, a groundbreaking drug discovery engine, leverages a new class of antigens with greater tumor specificity and a suite of technologies to significantly improve T cell memory, persistence, and sensitivity. The result is dramatic improvement in the body’s immune response to overcome disease. Mnemo is built by a transatlantic team of scientists and biotech leaders united in their mission to create the most powerful immune therapies to deliver accessible cures for all patients in need.